Interpretation of Key Points in 2024 Chinese Expert Consensus on EGFR Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer

Interpretation of Key Points in 2024 Chinese Expert Consensus on EGFR Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer

The Chinese Society of Clinical Oncology (CSCO) NSCLC Expert Committee has updated the 2023 Chinese expert consensus in light of the growing understanding of epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations in non-small cell lung cancer (NSCLC) and the emergence of new c...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuanhong JIN, Fei ZHOU
Format: Article
Language:Chinese
Published: Magazine House of Cancer Research on Prevention and Treatment 2025-06-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
non-small cell lung cancer
egfr exon 20 insertion
targeted therapy strategies
Online Access:http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.25.0120
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items